Literature DB >> 3839800

Pathophysiology of spontaneous hypercalciuria in laboratory rats. Role of deranged vitamin D metabolism.

K Lau, D Thomas, C Langman, B Eby.   

Abstract

Recent data suggest a causal role of deranged 1,25(OH)2D metabolism in the syndrome of idiopathic hypercalciuria. To test this hypothesis, we evaluated if vitamin D availability and/or increased serum 1,25(OH)2D were critical for the expression of hypercalciuria in laboratory rats. Ca balance, serum 25OHD3, and 1,25(OH)2D3 were studied in D-deprived (-D) and D-repleted (+D) male progeny (p) born to normocalciuric (NC) and spontaneously hypercalciuric (SH) rats. 7 of the 14 pSH and 2 of 21 pNC had SH, which was defined as urinary Ca greater than two standard deviations above the mean of values for control animals on days 5 and 6 of a low Ca +D diet (1.19 vs. 0.58 mg/d, P less than 0.001). Fasting serum Ca and 25OHD3 were similar to control. Serum 1,25(OH)2D3 was elevated in these nine SH rats (232 vs. 145 pg/ml, P less than 0.005). However, during vitamin D deprivation, their Ca excretion was also increased (1.53 vs. 0.45 mg/d, P less than 0.001), despite comparably reduced serum 1,25(OH)2D3 (102 vs. 106 pg/ml) and undetectable serum 25OHD3. Net intestinal Ca absorption on a low Ca diet was comparable during D repletion (-0.75 vs. -0.82 mg/d) or D deprivation (-0.80 vs. -2.15 mg/d), excluding primary hyperabsorption as the mediator of the hypercalciuria. Mild hypophosphatemia was present in SH on +D (5.8 vs. 6.9 mg/dl, P less than 0.005) and -D diets (6.2 vs. 7.9 mg/dl, P less than 0.005), and was associated with higher rates of cyclic adenosine monophosphate excretion (32.8 vs. 26.9 and 48.5 vs. 41.0 nmol/mg of creatinine, respectively). Spontaneous hypercalciuria is therefore dissociable from increased Ca absorption, serum levels of 25OHD3, or 1,25(OH)2D3. The data are most compatible with the hypothesis of a renal Ca leak which stimulates parathyroid hormone activity and increases serum 1,25(OH)2D3, if provided adequate 25OHD3 as substrate.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839800      PMCID: PMC423830          DOI: 10.1172/JCI111988

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels.

Authors:  M R Haussler; D J Baylink; M R Hughes; P F Brumbaugh; J E Wergedal; F H Shen; R L Nielsen; S J Counts; K M Bursac; T A McCain
Journal:  Clin Endocrinol (Oxf)       Date:  1976       Impact factor: 3.478

2.  Effects of calcitriol administration on calcium metabolism healthy men.

Authors:  N D Adams; R W Gray; J Lemann; H S Cheung
Journal:  Kidney Int       Date:  1982-01       Impact factor: 10.612

3.  Familial absorptive hypercalciuria in a large kindred.

Authors:  C Y Pak; J McGuire; R Peterson; F Britton; M J Harrod
Journal:  J Urol       Date:  1981-12       Impact factor: 7.450

4.  Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.

Authors:  A E Broadus; M Dominguez; F C Bartter
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

5.  Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate, and magnesium absorption in humans.

Authors:  D R Wilz; R W Gray; J H Dominguez; J Lemann
Journal:  Am J Clin Nutr       Date:  1979-10       Impact factor: 7.045

6.  Proximal tubular defects in idiopathic hypercalciuria: resistance to phosphate administration.

Authors:  Y K Lau; A Wasserstein; G R Westby; P Bosanac; M Grabie; P Mitnick; E Slatopolsky; S Goldfarb; Z S Agus
Journal:  Miner Electrolyte Metab       Date:  1982

7.  Calcium homeostasis in immobilization: an example of resorptive hypercalciuria.

Authors:  A F Stewart; M Adler; C M Byers; G V Segre; A E Broadus
Journal:  N Engl J Med       Date:  1982-05-13       Impact factor: 91.245

8.  Tubular mechanism for the spontaneous hypercalciuria in laboratory rat.

Authors:  K Lau; B K Eby
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

9.  Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function.

Authors:  R A Sutton; V R Walker
Journal:  N Engl J Med       Date:  1980-03-27       Impact factor: 91.245

10.  Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects.

Authors:  F L Coe; M J Favus; T Crockett; A L Strauss; J H Parks; A Porat; C L Gantt; L M Sherwood
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

View more
  4 in total

1.  Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.

Authors:  D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

2.  The effects of calcitonin on idiopathic nephrolithiasis. Evidence of bone involvement in fasting hypercalciuria.

Authors:  P Filipponi; C Mannarelli; G Gubbiotti; A Blass; I Moretti; S Tini; N Giuseppetti; S Ballanti; P Morucci
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

3.  Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption.

Authors:  X Q Li; V Tembe; G M Horwitz; D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

4.  Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria.

Authors:  P Filipponi; C Mannarelli; R Pacifici; E Grossi; I Moretti; S Tini; C Carloni; A Blass; P Morucci; K A Hruska
Journal:  Calcif Tissue Int       Date:  1988-08       Impact factor: 4.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.